Page 1 | Search Results | Blood | American Society of Hematology

Skip Nav Destination

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single- chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor

DA Vallera, A Panoskaltsis-Mortari, C Jost, S Ramakrishnan, CR Eide, RJ Kreitman, PJ Nicholls, C Pennell, BR Blazar

Blood (1996) 88 (6): 2342–2353.

https://doi.org/10.1182/blood.V88.6.2342.bloodjournal8862342

Published: 1996

Journal Articles

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, S Sehgal, DA Vallera

Blood (1996) 87 (9): 4001–4009.

https://doi.org/10.1182/blood.V87.9.4001.bloodjournal8794001

Published: 1996

Journal Articles

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, TA Barrett, JA Bluestone, DA Vallera

Blood (1996) 87 (2): 827–837.

https://doi.org/10.1182/blood.V87.2.827.bloodjournal872827

Published: 1996

Journal Articles

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin

DA Vallera, PA Taylor, A Panoskaltsis-Mortari, BR Blazar

Blood (1995) 86 (11): 4367–4375.

https://doi.org/10.1182/blood.V86.11.4367.bloodjournal86114367

Published: 1995

Journal Articles

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

BR Blazar, PA Taylor, A Panoskaltsis-Mortari, GS Gray, DA Vallera

Blood (1995) 85 (9): 2607–2618.

https://doi.org/10.1182/blood.V85.9.2607.bloodjournal8592607

Published: 1995

NARROW

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single- chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

Email alerts

ASH Publications

American Society of Hematology

Anti-graft-versus-host disease effect of DT390-anti-CD3sFv, a single- chain Fv fusion immunotoxin specifically targeting the CD3 epsilon moiety of the T-cell receptor

In vivo inhibition of cytokine responsiveness and graft-versus-host disease mortality by rapamycin leads to a clinical-pathological syndrome discrete from that observed with cyclosporin A

Lethal murine graft-versus-host disease induced by donor gamma/delta expressing T cells with specificity for host nonclassical major histocompatibility complex class Ib antigens

Therapy for ongoing graft-versus-host disease induced across the major or minor histocompatibility barrier in mice with anti-CD3F(ab')2-ricin toxin A chain immunotoxin

Coblockade of the LFA1:ICAM and CD28/CTLA4:B7 pathways is a highly effective means of preventing acute lethal graft-versus-host disease induced by fully major histocompatibility complex-disparate donor grafts

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only